PX1 Research provides reference-standard Chonluten for laboratory investigation into cell adhesion dynamics, bronchial epithelial gene expression, and extracellular matrix interactions. Designed exclusively for non-clinical research applications, every lot undergoes rigorous analytical validation to ensure maximum chemical identity and purity.
PX1 Research provides reference-standard Chonluten for laboratory investigation into cell adhesion dynamics, bronchial epithelial gene expression, and extracellular matrix interactions. Designed exclusively for non-clinical research applications, every lot undergoes rigorous analytical validation to ensure maximum chemical identity and purity.
When principal investigators seek to buy cell adhesion reduction Chonluten for analytical and cell culture models, sourcing validated purity is essential for reproducibility. Research-grade Chonluten (Glu-Asp-Gly) supplied by PX1 Research is manufactured in GMP-compliant domestic facilities under strict ISO 17025 laboratory standards. Every batch is supplied with lot-specific Certificate of Analysis (COA) data, confirming molecular identity, purity above standard research thresholds via RP-HPLC, and low endotoxin levels suitable for sensitive bioassays.
Investigators examining cell-cell interactions, integrin signaling, and cell adhesion molecule modulation require synthesized peptides free of TFA salts, heavy metal residues, and organic contaminants. Procurement through PX1 Research guarantees full supply chain transparency, same-day dispatch from our California and Arizona distribution hubs, and standard-compliant handling for consistent experimental outcomes.
Chonluten is a synthetic tripeptide consisting of the amino acid sequence L-glutamyl-L-asparagyl-glycine (Glu-Asp-Gly). Belonging to the class of short peptide bioregulators initially identified in Khavinson's peptide research framework, Chonluten is specifically designed to model targeted interactions within nuclear chromatin and gene promoter regions.
With a low molecular weight, the structure of Chonluten allows for rapid diffuse transport across cell membranes in vitro. Its primary chemical sequence contains acidic residues (glutamic and aspartic acid) paired with glycine, providing specific electrostatic profiles that facilitate binding within the minor groove of DNA. Researchers analyzing peptide bioregulators frequently evaluate how these short sequences influence transcription factor access, epigenetic marks, and downstream protein expression related to cell adhesion molecules (CAMs).
Preclinical studies suggest that short tripeptides like Chonluten regulate tissue homeostasis by binding directly to specific histone-DNA complexes. In assays measuring epithelial and endothelial behavior, Chonluten has demonstrated an ability to modulate the expression of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and selectins.
In vitro data indicate that under conditions of simulated inflammatory stress or cytokine stimulation (such as exposure to TNF-alpha or IL-6), Chonluten attenuates the hyper-upregulation of adhesion molecules on cell surfaces. By stabilizing chromatin structure and preventing the over-expression of pro-inflammatory adhesion proteins, the peptide alters leukocyte-endothelial binding kinetics. This reduction in cell adhesion is a central focal point for research groups evaluating mucosal tissue remodeling, neutrophil extravasation, and chronic epithelial stress responses.
In vitro assays utilizing human bronchial epithelial cell lines (such as 16HBE14o- or A549) have provided key insights into the functional activity of Chonluten. When exposed to environmental stressors or oxidative agents, control cultures exhibit marked increases in surface adhesion receptors, facilitating excessive cellular aggregation and altered tissue permeability. Cultures co-incubated with synthetic Chonluten demonstrate a statistically significant attenuation of surface marker expression.
Rodent models exploring pulmonary inflammation further demonstrate that administration of tripeptide bioregulators correlates with decreased neutrophil accumulation in bronchoalveolar lavage fluid. By reducing the physical adhesion of circulating immune cells to the vascular and airway epithelium, research indicates a preserving effect on tissue architecture and alveolar membrane integrity. These observations suggest a direct relationship between sequence-specific peptide interaction and the maintenance of standard cellular clearance mechanisms.
To contextualize the performance of Chonluten, laboratory researchers often compare its regulatory scope against other short-chain peptide bioregulators in the same structural class. While Chonluten specifically targets bronchial epithelial signaling and cell adhesion pathways, related peptides offer alternative organ- or tissue-specific affinities within our catalog of all research peptides.
For example, Bronchogen (Ala-Glu-Asp-Leu) is frequently evaluated alongside Chonluten in respiratory models, though Bronchogen displays broader action on surfactant protein expression and genomic repair mechanisms within lung fibroblasts. Similarly, Cartalax (Ala-Glu-Asp) targets chondrocyte differentiation and cartilage extracellular matrix synthesis, showing negligible influence on vascular adhesion molecules. Conversely, Vesegen (Lys-Glu-Asp) acts primarily on vascular endothelial cells, regulating nitric oxide synthases rather than mucosal cell adhesion complexes. Understanding these structural variations allows researchers to select the exact molecular candidate required for their specific bioassay design.
Chonluten is supplied as a lyophilized white powder to ensure long-term chemical stability during transport and storage. For analytical procedures, proper reconstitution protocols must be observed to prevent peptide aggregation or degradation.
Reconstitution should be performed using sterile Bacteriostatic Water, Sterile Water for Injection, or standard Phosphate-Buffered Saline (PBS, pH 7.4), depending on the requirements of the downstream in vitro or cell culture assay. The solvent should be gently introduced along the inner vial wall, allowing the lyophilized cake to dissolve without vigorous vortexing. Aliquoting the reconstituted stock solution into single-use polypropylene microcentrifuge tubes minimizes freeze-thaw cycles, which can induce hydrolytic cleavage of the amide bonds.
To maintain optimal peptide integrity, lyophilized Chonluten should be stored at -20°C upon receipt, protected from light and moisture. Under these conditions, the un-reconstituted compound remains stable for up to 24 months. For long-term archival storage, -80°C is recommended.
Once reconstituted in aqueous buffer or sterile solvent, stock solutions should be stored at 4°C for immediate short-term use (not exceeding 7 days) or aliquoted and frozen at -20°C or -80°C for up to 90 days. Avoid repeated exposure to ambient room temperatures and ensure all pipetting equipment utilized during assay preparation is free of nucleases and proteases.
The scientific validity of any cell adhesion or genetic assay relies entirely on the purity of the research reagents used. PX1 Research implements an exhaustive quality verification protocol for every production lot of Chonluten, ensuring full reproducibility across experimental replicates.
Purity is verified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), ensuring a baseline chemical purity of ≥98%. Mass Spectrometry (MS) analysis is simultaneously conducted to confirm exact molecular weight and sequence identity, eliminating the possibility of truncated fragments or side-reactions during solid-phase peptide synthesis. Furthermore, because cell adhesion assays are exceptionally sensitive to lipopolysaccharide (LPS) artifacts, all lots undergo chromogenic LAL testing to verify endotoxin levels are maintained well below standard cell culture thresholds (<0.01 EU/μg).
PX1 Research operates as a dedicated partner for academic institutions, biotechnology firms, and contract research organizations (CROs). We recognize that project timelines depend on reliable material availability and rigorous batch consistency. Our inventory of respiratory peptide models is managed directly within US-based facilities.
Institutional buyers seeking volume sourcing can establish bulk research accounts for streamlined procurement, dedicated account management, and standardized lot-reservation protocols. Every order ships same-day when placed before cut-off times from our dual fulfillment centers in California and Arizona, providing rapid transit and minimizing environmental exposure during shipping.
In current bioengineering research, Chonluten is actively used to investigate cellular migration rates, monolayer tight-junction integrity, and focal adhesion kinase (FAK) signaling cascades. By incorporating Chonluten into microfluidic lung-on-a-chip models, investigators can monitor real-time neutrophil rolling, adhesion, and transmigration across mucosal barriers.
Furthermore, researchers utilize Chonluten in combination with standard molecular biology tools—such as RT-qPCR, Western blotting, and immunofluorescence microscopy—to map out the exact chromatin binding sites of Glu-Asp-Gly. Reviewing published findings via our third-party COA documentation hub provides researchers with the necessary analytical benchmarks to validate their experimental controls.
What is Chonluten and what is its primary chemical structure?
Chonluten is a synthetic tripeptide bioregulator with the amino acid sequence L-glutamyl-L-asparagyl-glycine (Glu-Asp-Gly). It is synthesized for laboratory research to study gene regulation, tissue homeostasis, and cell adhesion dynamics.
How does Chonluten influence cell adhesion in preclinical models?
In vitro and animal models show that Chonluten modulates the expression of cell adhesion molecules such as ICAM-1 and VCAM-1, particularly under cytokine-stimulated or inflammatory conditions, leading to reduced cell-cell adhesion and altered leukocyte rolling dynamics.
Is Chonluten approved for human consumption or therapeutic use?
No. Chonluten provided by PX1 Research is strictly sold as a research peptide compound for in vitro, analytical, and preclinical laboratory applications. It is not intended for human or animal medical use, treatment, or administration.
What analytical methods are used to verify the purity of PX1 Research peptides?
Every lot of Chonluten undergoes Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity assessment, Mass Spectrometry (MS) for identity confirmation, and chromogenic LAL testing to ensure low endotoxin content.
How should lyophilized Chonluten be stored upon arrival?
Lyophilized Chonluten should be stored at -20°C (or -80°C for long-term storage), protected from light and moisture. Reconstituted solutions should be aliquoted and kept frozen to avoid damage from freeze-thaw cycles.
What solvent is recommended for reconstituting Chonluten for bioassays?
Chonluten is typically reconstituted in sterile Bacteriostatic Water, Sterile Water for Injection, or sterile Phosphate-Buffered Saline (PBS, pH 7.4), depending on the specific sensitivity and requirements of the cell culture or assay protocol.
How does Chonluten differ structurally from Bronchogen?
Chonluten is a tripeptide (Glu-Asp-Gly) primarily studied for bronchial epithelial and cell adhesion dynamics, whereas Bronchogen is a tetrapeptide (Ala-Glu-Asp-Leu) evaluated for broader lung tissue repair and surfactant protein modulation.
Where are PX1 Research compounds manufactured and shipped from?
PX1 Research compounds are manufactured in domestic, GMP-compliant facilities in the United States and shipped directly from our warehouse hubs located in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.